Søgeresultater - Nicolò Compagno
- Showing 1 - 7 results of 7
-
1
-
2
-
3
-
4
Clinical profile associated with infections in patients with chronic lymphocytic leukemia. Protective role of immunoglobulin replacement therapy af Andrea Visentin, Nicolò Compagno, Francesco Cinetto, Silvia Imbergamo, Renato Zambello, Francesco Piazza, Gianpietro Semenzato, Livio Trentin, Carlo Agostini
Udgivet 2015Carta -
5
Single-cell analysis of germinal-center B cells informs on lymphoma cell of origin and outcome af Antony B. Holmes, Clarissa Corinaldesi, Qiong Shen, Rahul Kumar, Nicolò Compagno, Zhong Wang, Mor Nitzan, Eli Grunstein, Laura Pasqualucci, Riccardo Dalla‐Favera, Katia Basso
Udgivet 2020Artigo -
6
Secukinumab in adult patients with lichen planus: efficacy and safety results from the randomized placebo-controlled proof-of-concept PRELUDE study af Thierry Passeron, Maximilian Reinhardt, Benjamin D. Ehst, Jonathan Weiss, Jason C. Sluzevich, Michael Sticherling, Pascal Reygagne, Johannes Wohlrab, Michael Hertl, Nasim Fazel, Elisa Muscianisi, Heng Fan, Isabelle Hampele, Nicolò Compagno
Udgivet 2024Artigo -
7
Safety of Crovalimab Versus Eculizumab in Patients With Paroxysmal Nocturnal Haemoglobinuria (<scp>PNH</scp>): Pooled Results From the Phase 3 <scp>COMMODORE</scp> Studies af Alexander Röth, Rong Fu, Guangsheng He, Hazzaa Alzahrani, Sheng‐Chieh Chou, Yosr Hicheri, Maciej Kaźmierczak, Viviane Lacorte Recôva, Michihiro Uchiyama, Ana‐Maria Vladareanu, Leigh Beveridge, Simon Buatois, Muriel Buri, Nicolò Compagno, Dayu Shi, Nadiesh Balachandran, Sasha Sreckovic, Phillip Scheinberg
Udgivet 2024Artigo
Søgeredskaber:
Relaterede emner
Immunology
Medicine
Antibody
Immune system
Internal medicine
Lymphoma
Adverse effect
Rituximab
Biology
Common variable immunodeficiency
Disease
Gastroenterology
Hypogammaglobulinemia
Lymphoproliferative disorders
Monoclonal antibody
Primary immunodeficiency
Alternative medicine
Antibiotics
Antibody therapy
Antigen
Antigen-presenting cell
Astrobiology
B cell
B-cell lymphoma
CD20
Cell
Cell biology
Cell of origin
Chronic lymphocytic leukemia
Clinical endpoint